tradingkey.logo
tradingkey.logo
Search

Sonoma Pharmaceuticals Inc

SNOA
Add to Watchlist
1.210USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
2.18MMarket Cap
LossP/E TTM

Sonoma Pharmaceuticals Inc

1.210
0.0000.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+8.04%

1 Month

0.00%

6 Months

-66.76%

Year to Date

-66.76%

1 Year

-59.26%

Key Figures
1.220Open
1.225High
60.65KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.37%Turnover Ratio
1.210Prev. Close
1.190Low
62.86KTurnover
LossP/E Static
0.70P/B
0.00%Div Yield TTM
-24.70%ROA
6.92052wk High
0.42Volume Ratio
-3.46MNet Profit
1.80MShares
-1.9416EPS TTM
1.29Beta
-81.19%ROE
0.85052wk Low
2.89%Amplitude
39.22%Gross Margin
2.18MMarket Cap
--Reward/Risk
4.46%Risk Rate

Key Insights

Sonoma Pharmaceuticals Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 126 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 14.80.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sonoma Pharmaceuticals Inc's Score

Industry at a Glance

Industry Ranking
126 / 157
Overall Ranking
433 / 4565
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sonoma Pharmaceuticals Inc Highlights

StrengthsRisks
Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.35% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.53M.
Fairly Valued
The company’s latest PE is -0.62, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 127.80K shares, decreasing 21.35% quarter-over-quarter.

Analyst Rating

Based on 0 analysts
--
Current Rating
14.800
Target Price
+1198.25%
Upside Space

Sonoma Pharmaceuticals Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sonoma Pharmaceuticals Inc Info

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.
Ticker SymbolSNOA
CompanySonoma Pharmaceuticals Inc
CEOTrombly (Amy)
Websitehttps://sonomapharma.com/

FAQs

What is the current price of Sonoma Pharmaceuticals Inc (SNOA)?

The current price of Sonoma Pharmaceuticals Inc (SNOA) is 1.21.

What is the symbol of Sonoma Pharmaceuticals Inc?

The ticker symbol of Sonoma Pharmaceuticals Inc is SNOA.

What is the 52-week high of Sonoma Pharmaceuticals Inc?

The 52-week high of Sonoma Pharmaceuticals Inc is 6.92.

What is the 52-week low of Sonoma Pharmaceuticals Inc?

The 52-week low of Sonoma Pharmaceuticals Inc is 0.85.

What is the market capitalization of Sonoma Pharmaceuticals Inc?

The market capitalization of Sonoma Pharmaceuticals Inc is 2.18M.

What is the Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA)?

The Earnings Per Share (EPS TTM) of Sonoma Pharmaceuticals Inc (SNOA) is -1.89.